K. Muth

Early bactericidal activity of isoniazid in pulmonary tuberculosis. Optimization of methodology. The DATRI 008 Study Group.

M. Egorin, L. Heifets, R. Hafner, 1997, American journal of respiratory and critical care medicine.

Toxicity of clindamycin as prophylaxis for AIDS-associated toxoplasmic encephalitis

M. Jacobson, R. Hafner, K. Muth, 1992, The Lancet.

The closeout process for a clinical trial terminated early for lagging enrollment and inadequate follow-up.

J. Ellenberg, K. Muth, E. Yu, 2001, Controlled clinical trials.

Primary prophylaxis with pyrimethamine for toxoplasmic encephalitis in patients with advanced human immunodeficiency virus disease: results of a randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS.

J P Matts, J. Neaton, D. Wentworth, 1994, The Journal of infectious diseases.

A comparative trial of didanosine or zalcitabine after treatment with zidovudine in patients with human immunodeficiency virus infection. The Terry Beirn Community Programs for Clinical Research on AIDS.

J. Neaton, N. Markowitz, R. Luskin-Hawk, 1994, The New England journal of medicine.

Correlation of quantitative bone marrow and blood cultures in AIDS patients with disseminated Mycobacterium avium complex infection.

G. Drusano, C. Inderlied, R. Hafner, 1999, The Journal of infectious diseases.

Two-stage tuberculin skin testing in individuals with human immunodeficiency virus infection

C. Salveson, K. Muth, F. Gordin, 1995 .

Clinical programs for clinical research on AIDS: Description of a randomized prospective study of clindamycin versus pyrimethamine for prevention ofToxoplasma gondii infection

M. Jacobson, R. Hafner, K. Muth, 1991, European Journal of Clinical Microbiology and Infectious Diseases.